CPH Pharma ApS — Credit Rating and Financial Key Figures

CPH Pharma ApS (CVR number: 37110248) is a company from FURESØ. The company recorded a gross profit of 3017 kDKK in 2023. The operating profit was 1325 kDKK, while net earnings were 1034.3 kDKK. The profitability of the company measured by Return on Assets (ROA) was 55.5 %, which can be considered excellent and Return on Equity (ROE) was 63.8 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 68.1 %, a level that can be considered to be good. This shows that a large part of the company's assets are funded by shareholders' equity, reducing financial risk. CPH Pharma ApS's liquidity measured by quick ratio was 3.1 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.